Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biopharmaceutical company. The Company’s principal activities are research, drug development and clinical trials of psilocybin products. The Company offers healthcare professionals a variety serotonin-modulating medications by developing drug families derived from Psilocybin and MDMA. The Company is developing several prodrug families, beginning with a psilocybin-derived smoking cessation drug undergoing a NIDA-funded trial at Johns Hopkins University. It is also developing MYCO-006, short-acting chemical analogs derived from MDMA for treating various conditions, including anxiety and pain. It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by busy4lifeon Jan 05, 2017 10:07pm

71 Views

Post# 25673599

RE:Anyone heard of CMED - cannimed therapeutics

Liteup.....u turd....... what are u doing talking abt CMED here.......as an FYI. .....I actually own CMED........one of my family members was sent to a mariuajana clinic in kitchener Ontario. .....ended up getting an oil prescribed to him from the clinic.....each small bottle was delivered to him directly from cannimed and cost 250 for the lowest dosee a month. Pain control was awesone. .....long story short...... 6 months later he has gone up on his dose twice and now pays 380 dollars a month for his maintenance dose. CMED is minting money rite now and they went live on Dec 29......I am in for 1600 shares at around 11 bucks........they are bigger and better than CGC....... if ur half as smart as u sound........just buy it and forget it for 6 months......it will be well over 20 bucks...... .